As an extension of ourselves technology is supposed to make our lives better. Maybe it streamlines a process or produces an efficiency where it’s needed. True innovation should help…
Diagnos
Today Equity.Guru founder, Chris Parry, speaks with Stefan Quenneville, Director of Life Sciences and Biotech Research at Echelon Wealth Partners, to get his take on Diagnos (ADK.V), a Canadian…
Diagnos (ADK.V) announced that their artificial intelligence program delivered world-class results in the GAMMA (Glaucoma GrAding from Multi-Modality imAges) contest, held alongside The Medical Imaging Computing and Computer-Assisted Intervention…
Diagnos (ADK.V) announced today that it has signed a 7-year contract with Juarez Health & Medical Tourism Cluster (“Cluster”), headquartered in Ciudad Juarez located in the State of Chihuahua,…
Diagnos (ADK.V) announced today that it has signed a 3-year contract with Cielo Vista Eye Clinic in Mexico. According to the contract, Diagnos will supply its CARA platform to…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Diagnos (ADK.V), a leader in early detection announced today that it has signed a pilot in Spain with three franchisees from Opticalia Group. “The campaign begins with the request…
On July 22, 2021 Diagnos (ADK.V) announced the official opening of the initial clinics at the Magrabi Hospital in Saudi Arabia. DIAGNOS specialises in early detection of health problems…
Diagnos (ADK.V) announced today that it has signed a two-month pilot with Hospital Oftalmologico Buena Vista Sinaloa (BVS), the largest ophthalmological hospital in Sinaloa state, Mexico. “Our focus is…
Diagnos (ADK.V) inked a multi-year agreement with IRIS The Visual Group 1990 to launch an artificial intelligence based testing platform to screen for vascular changes in the retina for…